January 26, 2018 / 6:14 PM / a year ago

Apotex CEO Desai resigns - Globe and Mail

Jan 26 (Reuters) - Generic drugmaker Apotex Inc’s Chief Executive Jeremy Desai resigned and will be replaced by his predecessor and co-founder Jack Kay, the Globe and Mail reported on Friday.

Desai “resigned to pursue other opportunities. His notice is effective immediately,” the newspaper said, citing a written statement from Apotex.

The company’s billionaire-founder Barry Sherman, who died in December, failed to implement a succession plan, potentially leaving it vulnerable to takeover approaches, Reuters had reported.

Apotex was not immediately available for comment. (Reporting by John Benny in Bengaluru; Editing by Anil D’Silva)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below